Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● The company is in a robust financial situation considering its net cash and margin position.

● Its low valuation, with P/E ratio at 2.25 and 3.95 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2021 fiscal year.

● The company appears to be poorly valued given its net asset value.

● The company has a low valuation given the cash flows generated by its activity.

● This company will be of major interest to investors in search of a high dividend stock.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the past twelve months, EPS forecast has been revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.